BECTON DICKINSON's PURCHASE OF OHMEDA MEDICAL DEVICE DIVISION WILL ADD $140 MIL. IN ANNUAL EUROPEAN REVENUES; $425 MIL. CASH DEAL IS FIRM's LARGEST EVER
This article was originally published in The Gray Sheet
Executive Summary
Becton Dickinson will substantially increase the sales of its I.V. catheters and critical care products in Europe with the purchase of Ohmeda's medical devices division (MDD) from BOC Group. Last year, about $140 mil. of the unit's $200 mil. in revenues were generated Europe.